Rationale and Analysis of the Use of ETDNO in the Treatment of PIPJ Flexion Contracture:

Sponsor
Vicenç Punsola Izard (Other)
Overall Status
Completed
CT.gov ID
NCT05465603
Collaborator
(none)
60
1
2
11.4
5.3

Study Details

Study Description

Brief Summary

Introduction: Flexion contracture is one of the most frequent complications in finger trauma. The use of orthoses to obtain the best total end range time (TERT) is the most popular method to treat this pathology . Until now, no orthosis applied for longer than 3 weeks had been able to achieve TERT longer than 12 hours.

Purpose of the study: To assess whether the elastic tension digital neoprene orthosis (ETDNO), using a serial dynamic program, can achieve a better result in ROM and TERT than other orthoses described in the literature.

Methods: analysis of outcomes in a sample of 30 patients with PIP joint flexion contracture treated with the ETDNO and serial dynamic program.

Condition or Disease Intervention/Treatment Phase
  • Device: ETDNO (Elastic Tension digital neoprene orthosis)
N/A

Detailed Description

In this study the researcher will compare the efect of daily TERT treatment on the proximal interphalangeal joint contracture using an ETDNO. The investigator will treat two different groups one with a dose of from 11 to 13 hours of the ETDNO while the other one is treated with a dose of from 20 to 22 hours of daily TERT with the same device. This treatment will last three weeks and will be evalauted the first day, the he first week and the third week. At the end of the study the researcher will quantify the improvement on both groups to know which dailyTERT dose is the best option.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Patients do not know which dose they are reciving compared to the other group
Primary Purpose:
Treatment
Official Title:
Rationale for the Use of Elastic Tension Digital Neoprene Orthoses in the Treatment of Proximal Interphalangeal Joint Flexion Contracture: Long Term Results
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Dec 1, 2021
Actual Study Completion Date :
Dec 14, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: 20-22 hours of daily TERT intervention

Patients that have suffered an injury to the finger causing flexion contracture of the Proximal interphalangeal joint will be treated using an elastic tension neoprene orthosis for a period of 6 months.

Device: ETDNO (Elastic Tension digital neoprene orthosis)
A bespoke orthosis created from neoprene.

Active Comparator: 11-13 hours daily TERT intervention

Patients that have suffered an injury to the finger causing flexion contracture of the Proximal interphalangeal joint will be treated using an elastic tension neoprene orthosis for a period of 6 months.

Device: ETDNO (Elastic Tension digital neoprene orthosis)
A bespoke orthosis created from neoprene.

Outcome Measures

Primary Outcome Measures

  1. Extension improvement [6 months]

    The degree of extension of the PIP at the end of the treatment compared with the beginning

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • PIP flexion contracture
Exclusion Criteria:
  • more than 6 month of contracture and more than 45º of flexion contracture

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hand Therapy Barcelona Barcelona Catalonia Spain 08010

Sponsors and Collaborators

  • Vicenç Punsola Izard

Investigators

  • Study Director: Josep Maria Potau, PhD, University of Barcelona

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vicenç Punsola Izard, Physical Therapist, Certified Hand Therapist in Hand Therapy Barcelona, MSc Gimbernat Universiy , Assistant lecturer at Gimbernat University, PhD Candidate at University of Barcelona, Hand Therapy Barcelona
ClinicalTrials.gov Identifier:
NCT05465603
Other Study ID Numbers:
  • 001
First Posted:
Jul 20, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2022